Cargando…

Self‐Report versus Clinician Examination in Early Parkinson's Disease

BACKGROUND: Evaluating the discrepancies between patient‐reported measures and clinician examination has implications for formulating individual treatment regimens. OBJECTIVE: This study investigated the association between health outcomes and level of self‐reported motor‐related function impairment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zolfaghari, Sheida, Thomann, Alessandra E., Lewandowski, Natalia, Trundell, Dylan, Lipsmeier, Florian, Pagano, Gennaro, Taylor, Kirsten I., Postuma, Ronald B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299700/ https://www.ncbi.nlm.nih.gov/pubmed/34897818 http://dx.doi.org/10.1002/mds.28884

Ejemplares similares

Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial
por: Lipsmeier, Florian, et al.
Publicado: (2018)

Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
por: Lipsmeier, Florian, et al.
Publicado: (2022)

Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
por: Kremer, Thomas, et al.
Publicado: (2021)

Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder
por: Zolfaghari, Sheida, et al.
Publicado: (2022)

Identifying prodromal symptoms at high specificity for Parkinson’s disease
por: Jackson, Holly, et al.
Publicado: (2023)

Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2019)

Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
por: Abbasi, Nooshin, et al.
Publicado: (2019)

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
por: Dadar, Mahsa, et al.
Publicado: (2018)

Reply to: “Association between Microscopic Colitis and Parkinson's Disease in a Swedish Population”
por: Kang, Xiaoying, et al.
Publicado: (2021)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Clinician knowledge and behaviors related to the 4Ms framework of Age‐Friendly Health Systems
por: Lesser, Sarah, et al.
Publicado: (2021)

Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter?
por: Campese, Nicole, et al.
Publicado: (2021)

Low‐fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial
por: Phillips, Matthew C.L., et al.
Publicado: (2018)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease
por: Onofrj, Marco, et al.
Publicado: (2021)

Examining the role of pre‐pregnancy weight and gestational weight gain in allergic disease development among offspring: A population‐based cohort study in Ontario, Canada
por: Srugo, Sebastian A., et al.
Publicado: (2021)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
por: Skrahina, Volha, et al.
Publicado: (2020)

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

GP2: The Global Parkinson's Genetics Program
Publicado: (2021)

Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2020)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
por: Iwaki, Hirotaka, et al.
Publicado: (2021)

Neuroimaging in Glucocerebrosidase‐Associated Parkinsonism: A Systematic Review
por: Filippi, Massimo, et al.
Publicado: (2022)

A Multi‐Step Model of Parkinson's Disease Pathogenesis
por: Le Heron, Campbell, et al.
Publicado: (2021)

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
por: Omer, Nurit, et al.
Publicado: (2021)

Patient, clinician and manager experience of the accelerated implementation of virtual consultations following COVID‐19: A qualitative study of preferences in a tertiary orthopaedic rehabilitation setting
por: Gilbert, Anthony W., et al.
Publicado: (2022)

An investigation of the level of burnout and resilience among hospital based nurse managers after COVID 19 — A cross‐sectional questionnaire‐based study
por: Pallesen, Kirsten Siig, et al.
Publicado: (2022)

EARLY FLOWERING3 sub-nuclear localization responds to changes in ambient temperature
por: Ronald, James, et al.
Publicado: (2021)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

The Parkinson's Disease Genome‐Wide Association Study Locus Browser
por: Grenn, Francis P., et al.
Publicado: (2020)

Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's Disease
por: Helmich, Rick C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fd64o01heu85tlo64s0h577u61